1994
DOI: 10.1073/pnas.91.11.5012
|View full text |Cite
|
Sign up to set email alerts
|

Specific association between the human DNA repair proteins XPA and ERCC1.

Abstract: Processing ofDNA damage by the nucleotideexcision repair pathway in eukaryotic cells is most likely accomplished by multiprotein complexes. However, the nature of these complexes and the details of the molecular interactions between DNA repair factors are for the most part unknown. Here, we demonstrate both in vivo, using the two-hybrid system, and in vitro, using recombinant proteins, that the human repair factors XPA and ERCC1 specificafly interact. In addition, we report an initial determination of the doma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
186
1
2

Year Published

1996
1996
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 271 publications
(194 citation statements)
references
References 31 publications
5
186
1
2
Order By: Relevance
“…Within the N-terminal domain of XPA is a region encoded by exon 2 that associates with ERCC1 and is essential for NER activity (Fig. 4) [21,25]. The 12 bp deletion created in this region has been shown to inhibit the ability of XPA to interact with ERCC1 and to increase repair activity in XPA cells or extracts [21].…”
Section: Discussionmentioning
confidence: 99%
“…Within the N-terminal domain of XPA is a region encoded by exon 2 that associates with ERCC1 and is essential for NER activity (Fig. 4) [21,25]. The 12 bp deletion created in this region has been shown to inhibit the ability of XPA to interact with ERCC1 and to increase repair activity in XPA cells or extracts [21].…”
Section: Discussionmentioning
confidence: 99%
“…For yeast two-hybrid analysis, pLexA-NLS (containing LexA DB domain; Vojtek et al, 1993) and pACTII (containing transcriptional AD domain; Li et al, 1994) were used as expression vectors. pSLY101 (DB-SLY1), pRG42 (AD-RGA), pRG225 (AD-rga-D17), pGAI102 (AD-GAI), pgai-1 (AD-gai-D17), and AD fusions with GAI truncations (GAI-NT1 [amino acids 1 to 157], GAI-CT1 [amino acids 92 to 532], GAI-CT2 [amino acids 151 to 532], and GAI-CT3 [amino acids 223 to 532]) were made previously .…”
Section: Plasmid Constructsmentioning
confidence: 99%
“…A Gateway ® cassette was introduced downstream and in frame with Gal4DB 2. pACT2-gw: pACT2 is commercialized by Clontech (12). It is a prey vector, encoding Gal4AD domain (aa 768-881) under the control of ADH1 promoter (see Note 4) …”
mentioning
confidence: 99%